Magnesium sulfate for preeclampsia in overweight women
Part of Women’s health & pregnancy clinical trials.
This study tests two different doses of magnesium sulfate to control seizures in overweight and obese women with preeclampsia. The goal is to find which dose works better and is safer for you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with preeclampsia (high blood pressure during pregnancy).
- You are between 20 and 40 years old.
- Your body mass index (BMI) is over 25 (you are overweight or obese).
- You are at least 28 weeks pregnant.
- You do not have conditions like myasthenia gravis, severe kidney failure, or heart block that would make magnesium sulfate unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a common seizure medication (levetiracetam) with the standard drug (magnesium sulfate) to see which works better at preventing seizures in women with severe preeclampsia, a complication of pregnancy. If you are pregnant or have recently given birth and have severe preeclampsia or HELLP syndrome, you may be able to join.
This study looks for genes that may be linked to severe preeclampsia, a serious blood pressure condition in pregnancy. It compares women with severe preeclampsia to those with healthy pregnancies to understand why it happens.
This trial tests whether a water pill (furosemide) helps women recover better after severe preeclampsia—a serious pregnancy complication marked by very high blood pressure. You'll be in the hospital postpartum, and researchers want to see if the medication speeds recovery and reduces complications.
This study looks at different ways to give magnesium sulphate to women with severe preeclampsia to find the best treatment plan.
This study looks at how biomarkers (specific substances in your blood) might help doctors better manage postpartum preeclampsia—high blood pressure and other symptoms that can appear after having a baby. You may qualify if you have severe preeclampsia during delivery or are receiving standard care after delivery.
This study tests whether giving magnesium sulphate (a mineral treatment) to pregnant women at risk of delivering very early (32–35 weeks) can protect the baby's brain and nervous system. The treatment is given before labor starts.
Hear when a new Severe Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.